Riskpilot← Back to searchSign inGet full accessTORREAUGE AS
ASActiveOrg 923104291Symrevegen 14, 6103 VoldaRental and operating of own or leased real estate · NACE 6820Est. 20190 employees
Revenue 2024
NOK 698K
+6% vs 2023
EBITDA margin
76.2%
+4% vs 2023
Equity ratio
18.1%
Financial strength
Net profit 2024
NOK 39K
+15% vs 2023
| Revenue | NOK 698K | +6% |
| EBITDA | NOK 532K | +4% |
| Net profit | NOK 39K | +15% |
| Total assets | NOK 5,1M | -5% |
| Equity | NOK 929K | +4% |
| Employees | 0 | — |
Legal name
TORREAUGE AS
Org number
923104291
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
17. juli 2019
Share capital
NOK 800 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Sal av kliniske tenester og optiske hjelpemiddel, samt andre produkt som naturleg fell saman med dette. Selskapet skal vidare kunne kjøpe, selge, drive og forvalte fast eigedom i inn- og utland. Selskapet kan delta i andre selskap med liknande verksemd ved kjøp av aksjar eller andelar.
Address
Symrevegen 14, 6103 Volda
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 321 | 328 | 432 | 657 | 698 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −7 | 243 | 252 | 336 | 513 | 532 |
| Depreciation & amort. | −0 | −119 | −119 | −147 | −201 | −201 |
| EBIT | −7 | 124 | 133 | 189 | 311 | 330 |
| Net financials | −9 | −104 | −89 | −133 | −245 | −256 |
| Profit before tax | −17 | 19 | 45 | 57 | 66 | 74 |
| Tax | −0 | 10 | 20 | 17 | 32 | 35 |
| Net profit | −17 | 9 | 25 | 40 | 34 | 39 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 3 277 | 3 232 | 3 156 | 5 328 | 5 401 | 5 127 |
| Equity | 783 | 792 | 817 | 857 | 890 | 929 |
| Long-term debt | 2 485 | 2 396 | 2 264 | 3 981 | 3 783 | 3 610 |
| Short-term debt | 9 | 44 | 75 | 490 | 728 | 588 |
| Total debt | 2 494 | 2 439 | 2 340 | 4 471 | 4 511 | 4 198 |
EBITDA margin
76.2%
This company
15.8%
Market median
+382% vs market
20192024
Equity ratio
18.1%
This company
38.2%
Market median
-53% vs market
20192024
Return on equity
4.2%
This company
18.4%
Market median
-77% vs market
20192024
Net profit margin
5.6%
This company
8.1%
Market median
-31% vs market
20192024
Asset turnover
0.14×
This company
1.12×
Market median
-88% vs market
20192024
Debt / equity
4.52×
This company
0.62×
Market median
-629% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-06-14 – 2019-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Nymark Invest As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nymark Invest As
TORREAUGE AS Board members of TORREAUGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gitte Nymark | Board of Directors | 0 companies |
| John Abraham Nymark | Chairman | 0 companies |